| Literature DB >> 17640535 |
Abstract
Myocardial infarction is a key component of the burden of cardiovascular disease. The assessment of the incidence and case fatality of myocardial infarction are important determinants of the decline in coronary disease mortality. The change in biomarkers used to diagnose myocardial infarction raises several methodologic, clinical, and public health challenges, which are discussed herein.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17640535 PMCID: PMC2537993 DOI: 10.1016/j.mcna.2007.03.007
Source DB: PubMed Journal: Med Clin North Am ISSN: 0025-7125 Impact factor: 5.456